| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 房地产业务(元) | 456,236,091.92 | 914,389,266.57 | 96,568,105.52 | 644,472,689.91 | 107,886,469.18 |
| 服务业(元) | 20,166,829.76 | 38,353,707.41 | 18,281,789.93 | 34,107,095.73 | 14,647,695.76 |
| 制药业(元) | 6,162,368,839.78 | 13,613,296,638.00 | 6,053,212,018.31 | 11,948,609,181.07 | 5,708,802,014.91 |
| 营业成本(元) | |||||
| 房地产业务(元) | 361,476,465.08 | 709,100,422.44 | - | 477,163,945.49 | 73,248,091.83 |
| 服务业(元) | 14,122,665.45 | 28,426,667.34 | - | 28,600,401.05 | 10,274,529.24 |
| 制药业(元) | 645,224,498.66 | 1,306,422,816.34 | 617,771,629.64 | 1,009,108,698.87 | 449,468,838.95 |
| 毛利(元) | |||||
| 房地产业务(元) | 94,759,626.84 | 205,288,844.13 | - | 167,308,744.42 | 34,638,377.35 |
| 服务业(元) | 6,044,164.31 | 9,927,040.07 | - | 5,506,694.68 | 4,373,166.52 |
| 制药业(元) | 5,517,144,341.12 | 12,306,873,821.66 | 5,435,440,388.67 | 10,939,500,482.20 | 5,259,333,175.96 |
| 毛利率(%) | |||||
| 房地产业务(%) | 20.77 | 22.45 | - | 25.96 | 32.11 |
| 服务业(%) | 29.97 | 25.88 | - | 16.15 | 29.86 |
| 制药业(%) | 89.53 | 90.40 | 89.79 | 91.55 | 92.13 |
| 收入构成(%) | |||||
| 房地产业务(%) | 6.87 | 6.28 | 1.57 | 5.10 | 1.85 |
| 服务业(%) | 0.30 | 0.26 | 0.30 | 0.27 | 0.25 |
| 制药业(%) | 92.82 | 93.46 | 98.14 | 94.63 | 97.90 |
| 毛利构成(%) | |||||
| 房地产业务(%) | 1.69 | 1.64 | 0.00 | 1.51 | 0.65 |
| 服务业(%) | 0.11 | 0.08 | 0.00 | 0.05 | 0.08 |
| 制药业(%) | 98.21 | 98.28 | 100.00 | 98.44 | 99.26 |